US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...
Prescott eNews15 小时
Pharmacy Leader Warns of Counterfeit Weight-Loss Drug Crisis – Inside Sources
Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...
The Hill5 天
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the market.
The Washington Post12 天
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly and its rival Novo Nordisk, which makes the diabetes drug Ozempic ... ahead of approval. States and the FDA inspect the compounding pharmacies that make weight-loss drugs, but they ...